Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PDE2A | O00408 | 3/20 | 0.36 |
| ▸ | MEN1 | O00255 | 1/20 | 0.33 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.33 |
| ▸ | MAPT | P10636 | 1/20 | 0.33 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.33 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.33 |
| ▸ | CSNK2A2 | P19784 | 1/20 | 0.31 |
| ▸ | CSNK2B | P67870 | 1/20 | 0.31 |
| ▸ | CSNK2A1 | P68400 | 1/20 | 0.31 |
| ▸ | RAPGEF4 | Q8WZA2 | 2/20 | 0.31 |
| ▸ | PDK2 | Q15119 | 1/20 | 0.30 |
| ▸ | DRD2 | P14416 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL91668 | 0.96 | ALDH1A1 (0.35) | PDE2AMEN1ALDH1A1MAPTKMT2A | |
| SCHEMBL6382158 | 0.79 | ALDH1A1 (0.40) | MEN1ALDH1A1MAPTKMT2ASMN1; SMN2 | |
| SCHEMBL19665045 | 0.78 | RXRA (0.45) | PDE2AALDH1A1 | |
| SCHEMBL1044722 | 0.77 | MEN1 (0.47) | MEN1ALDH1A1MAPTKMT2ASMN1; SMN2 | |
| SCHEMBL30507312 | 0.76 | ACHE (0.48) | ALDH1A1RAPGEF4 | |
| SCHEMBL22795543 | 0.75 | PDE2A (0.43) | PDE2AALDH1A1MAPT | |
| SCHEMBL91699 | 0.74 | FFAR4 (0.34) | — | |
| SCHEMBL91660 | 0.73 | RAPGEF4 (0.33) | MEN1ALDH1A1MAPTKMT2ASMN1; SMN2 | |
| SCHEMBL17431646 | 0.72 | ESRRA (0.39) | PDE2AMEN1ALDH1A1MAPTKMT2A | |
| SCHEMBL817545 | 0.71 | ACHE (0.50) | PDE2AALDH1A1MAPT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20160096852-A1 | Synthesis of 4-(pentafluorosulfanyl)benzenediazonium tetrafluoroborate and Analogs | UNIVERSITY OF NORTH FLORIDA (US) | 2016-04-07 | — | — | US | disclosed |
| US-9284336-B1 | Synthesis of 4-(pentafluorosulfanyl)benzenediazonium tetrafluoroborate and analogs | UNIVERSITY OF NORTH FLORIDA (US) | 2016-03-15 | — | — | US | disclosed |
| US-9238660-B1 | Synthesis of 4-(pentafluorosulfanyl)benzenediazonium tetrafluoroborate and analogs and their application for the preparation of SF5-aromatics | UNIVERSITY OF NORTH FLORIDA (US) | 2016-01-19 | — | — | US | disclosed |
| US-8129002-B2 | Compounds for use in liquid crystal media | MERCK PATENT GMBH (DE) | 2012-03-06 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20160096852-A1 | Synthesis of 4-(pentafluorosulfanyl)benzenediazonium tetrafluoroborate and Analogs | HCK, NEK5, SIK2 | PDE2A 4703/4885MEN1 3596/4885ALDH1A1 2964/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.